(Consultation procedure)

The European Parliament ,

–   having regard to the Commission proposal (COM(2007)0430),

–   having regard to Article 34(2)(c) of the EU Treaty,

–   having regard to Article 39(1) of the EU Treaty, pursuant to which the Council consulted Parliament (C6-0285/2007),

–   having regard to Rules 93 and 51 of its Rules of Procedure,

–   having regard to the report of the Committee on Civil Liberties, Justice and Home Affairs (A6-0417/2007),

1.  Approves the Commission proposal as amended;

2.  Calls on the Commission to alter its proposal accordingly, pursuant to Article 250(2) of the EC Treaty;

3.  Draws the attention of the Commission and the Council to the lack of conclusive scientific evidence in the risk assessment report on which the Commission proposal is based, particularly as regards evidence of overall risks and harm caused by this substance, and stresses that further studies are needed;

4.  Calls on the Council to notify Parliament if it intends to depart from the text approved by Parliament;

5.  Calls on the Council to consult Parliament again if it intends to amend the Commission proposal substantially;

6.  Instructs its President to forward its position to the Council and the Commission.

Text proposed by the Commission   Amendment by Parliament Amendments 3 and 6 Article 1 Member States shall take the necessary measures, in accordance with their national law, to submit 1-benzylpiperazine (also known as 1-benzyl-1, 4-diazacyclohexane, N-benzylpiperazine or – less precisely – as benzylpiperazine or BZP) to control measures, proportionate to the risks of the substance, and criminal penalties, as provided for under their legislation complying with their obligations under the 1971 United Nations Convention on Psychotropic Substances . Member States shall take the necessary measures, in accordance with their national law, to submit 1-benzylpiperazine (also known as 1-benzyl-1, 4-diazacyclohexane, N-benzylpiperazine or – less precisely – as benzylpiperazine or BZP) to mere control measures, proportionate to the low and still to be researched and proven risks of the substance.